Lee M - Search Results

1

Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma.

Schiller G, Nimer S, Vescio R, Lieb G, Lee M, Gajewski J, Territo M, Berenson J. Schiller G, et al. Among authors: lee m. Bone Marrow Transplant. 1994 Jul;14(1):131-6. Bone Marrow Transplant. 1994. PMID: 7951100 Clinical Trial.

2

Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.

Przepiorka D, Khouri I, Thall P, Mehra R, Lee MS, Ippoliti C, Giralt S, Gajewski J, van Besien K, Andersson B, Körbling M, Deisseroth AB, Champlin R. Przepiorka D, et al. Among authors: lee ms. Bone Marrow Transplant. 1999 May;23(10):977-81. doi: 10.1038/sj.bmt.1701764. Bone Marrow Transplant. 1999. PMID: 10373061 Clinical Trial.

3

Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma.

Schiller G, Vescio R, Freytes C, Spitzer G, Sahebi F, Lee M, Wu CH, Cao J, Lee JC, Hong CH, et al. Schiller G, et al. Among authors: lee jc, lee m. Blood. 1995 Jul 1;86(1):390-7. Blood. 1995. PMID: 7540888 Free article. Clinical Trial.

4

Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma.

Schiller G, Vescio R, Freytes C, Spitzer G, Lee M, Wu CH, Cao J, Lee JC, Lichtenstein A, Lill M, Berenson R, Berenson J. Schiller G, et al. Among authors: lee jc, lee m. Bone Marrow Transplant. 1998 Jan;21(2):141-5. doi: 10.1038/sj.bmt.1701055. Bone Marrow Transplant. 1998. PMID: 9489630 Clinical Trial.

5

Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.

Schiller G, Gajewski J, Territo M, Nimer S, Lee M, Belin T, Champlin R. Schiller G, et al. Among authors: lee m. Blood. 1992 Dec 15;80(12):2977-82. Blood. 1992. PMID: 1467513 Free article. Clinical Trial.

6

A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia.

Schiller G, Gajewski J, Nimer S, Territo M, Ho W, Lee M, Champlin R. Schiller G, et al. Among authors: lee m. Br J Haematol. 1992 Jun;81(2):170-7. doi: 10.1111/j.1365-2141.1992.tb08203.x. Br J Haematol. 1992. PMID: 1643014 Clinical Trial.

7

Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.

Schiller G, Gajewski J, Lee M, Ho W, Territo M, Champlin R. Schiller G, et al. Among authors: lee m. Leuk Lymphoma. 1994 Sep;15(1-2):85-90. doi: 10.3109/10428199409051682. Leuk Lymphoma. 1994. PMID: 7858506

8

Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study.

Schiller G, Nimer S, Gajewski J, Lee M, Ho W, Territo M, Champlin R. Schiller G, et al. Among authors: lee m. Leuk Lymphoma. 1993 Sep;11(1-2):69-77. doi: 10.3109/10428199309054732. Leuk Lymphoma. 1993. PMID: 8220156 Clinical Trial.

9

Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia.

Schiller G, Lee M, Territo M, Gajewski J, Nimer S. Schiller G, et al. Among authors: lee m. Am J Hematol. 1993 Jul;43(3):195-9. doi: 10.1002/ajh.2830430307. Am J Hematol. 1993. PMID: 8352235 Clinical Trial.

10

Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for older patients with acute myelogenous leukemia.

Schiller G, Lee M. Schiller G, et al. Among authors: lee m. Leuk Lymphoma. 1997 Mar;25(1-2):111-9. doi: 10.3109/10428199709042501. Leuk Lymphoma. 1997. PMID: 9130619 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,580 results

Search Page

Filters